Karla Kennedy, MD
NPI 1720079908 · Obstetrics & Gynecology Physician · Birmingham, AL
Enrolled with Medicare as Practitioner - Obstetrics/Gynecology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1720079908
- Entity type
- Individual
- Primary specialty
- Obstetrics & Gynecology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Female
- Sole proprietor
- No
- License
- AL16422 (AL)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
333 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Screening 3d Breast Mammography77063 | 94 | $20 |
| Screening Mammography77067 | 94 | $74 |
| Cervical Or Vaginal Cancer Screening; Pelvic and Clinical Breast ExaminationG0101 | 63 | $33 |
| Screening Papanicolaou Smear; Obtaining, Preparing and Conveyance of Cervical Or Vaginal Smear to LaboratoryQ0091 | 58 | $37 |
| Diagnostic Digital Breast Tomosynthesis, Unilateral Or Bilateral (list Separately in Addition to 77065 Or 77066)G0279 | 13 | $16 |
| Limited Ultrasound Scan of 1 Breast76642 | 11 | $43 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 13 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Estradiol | 99 | 35 |
| Fluconazole | 32 | 12 |
| Estrogens, Conjugatedbrand: Premarin | 30 | — |
| Estradiolbrand: Estradiol (twice Weekly) | 27 | — |
| Progesterone, Micronizedbrand: Progesterone | 23 | — |
| Ibandronate Sodium | 16 | — |
| Valacyclovir Hclbrand: Valacyclovir | 16 | — |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$630 across 33 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-11-04
- Last updated
- 2021-04-07
- Certified
- 2021-04-07
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.